Related references
Note: Only part of the references are listed.A systematic review of the methods used to assess the association between appropriate antibiotic therapy and mortality in bacteremic patients
Jessina C. McGregor et al.
CLINICAL INFECTIOUS DISEASES (2007)
Controlling for severity of illness in assessment of the association between antimicrobial-resistant infection and mortality: Impact of calculation of acute physiology and chronic health evaluation (APACHE) II scores at different time points
Keith W. Hamilton et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2007)
Impact of empiric antibiotic therapy on outcomes in patients with Pseudomonas aeruginosa bacteremia
Regina B. Osih et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2007)
Multildrug-resistant Acinetobacter infection mortality rate and length of hospitalization
Rebecca H. Sunenshine et al.
EMERGING INFECTIOUS DISEASES (2007)
Comparison of severity of illness scoring systems for patients with nosocomial bloodstream infection due to Pseudomonas aeruginosa
Alexandre R. Marra et al.
BMC INFECTIOUS DISEASES (2006)
Nosocomial bloodstream infections caused by Klebsiella pneumoniae:: impact of extended-spectrum β-lactamase (ESBL) production on clinical outcome in a hospital with high ESBL prevalence -: art. no. 24
AR Marra et al.
BMC INFECTIOUS DISEASES (2006)
Utility of the Chronic Disease Score and Charlson Comorbidity Index as comorbidity measures for use in epidemiologic studies of antibiotic-resistant organisms
JC McGregor et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2005)
Nosocomial bloodstream infections in US hospitals: Analysis of 24,179 cases from a prospective nationwide surveillance study
H Wisplinghoff et al.
CLINICAL INFECTIOUS DISEASES (2004)
Bloodstream infections due to extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae:: Risk factors for mortality and treatment outcome, with special emphasis on antimicrobial therapy
CI Kang et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2004)
Pseudomonas aeruginosa bacteremia:: Risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome
CI Kang et al.
CLINICAL INFECTIOUS DISEASES (2003)
Inappropriate initial antimicrobial therapy and its effect on survival in a clinical trial of immunomodulating therapy for severe sepsis
S Harbarth et al.
AMERICAN JOURNAL OF MEDICINE (2003)
Share Paper
